BrightInsight

Founded in 2017, BrightInsight has positioned itself as a pivotal player in the digital health sector. They offer a cutting-edge, cloud-based platform that facilitates rapid development and scaling of digital health solutions, including companion apps, algorithms, and Software as a Medical Device (SaMD). As the industry's trusted foundation, their platform supports life sciences companies in leveraging unique real-world data to enhance therapeutic differentiation and drive measurable ROI.

BrightInsight has consistently demonstrated its ability to deliver tangible business and clinical outcomes, securing its role as a leader for prominent life sciences firms in key markets. The company, headquartered in the United States, recently garnered attention with a Late VC investment on January 1, 2026. This investment round was led by seasoned investors such as Insight Partners, Eclipse Ventures, New Leaf Venture Partners, General Catalyst, and the Mayo Clinic, cementing its status as a significant force in digital health innovation.